All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Introducing
Now you can personalise
your Lymphoma Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene and Roche, and supported through educational grants from Bristol Myers Squibb, Ipsen Biopharmaceuticals, Pfizer, and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC View funders.
Professor Won Kim is a Professor of Hematology and Oncology at the Samsung Medical Center, Sungkyunkwan University, Seoul, KR.
Prof. Kim carried out all of his medical education at the Seoul National University College of Medicine, KR, as well as his clinical fellowship in hematology-oncology. He has also obtained a postdoctoral fellowship from the National Institutes of Health, Maryland, US.
Prof. Kim’s current areas of research interest lie around immunotherapies, small molecule inhibitors, apoptosis, cell cycle, vaccines, and novel agents.
Positions of responsibility/awards: